From April 24th to April 26th 2025, the EXPOMED EURASIA 2025 exhibition was held in Istanbul, Turkey. EXPOMED EURASIA 2025 attracted the attention of the global medical industry, opened grandly. As one of the largest and most influential medical and health industry event in Middle East, the EXPOMED EURASIA 2025 brought together more than 26,000 industry visitors and more than 700 top exhibitors from around the world, covering multiple fields such as medical devices, biotechnology, and smart medicine, becoming a core platform for global companies to showcase cutting-edge technologies and deepen regional cooperation.

China's leading absorbable biomaterial company, Singclean Medical, brought its innovative products to the exhibition, lighting up the future of Eurasian medical care with its "intelligent manufacturing" strength, and won high attention from the Turkish market.
"Intelligent Manufacturing" Leads the Future: Singclean Brand Shines on the Eurasian Stage
Singclean Medical's focusing on its independently developed hyaluronic acid (HA) technology matrix. As a pioneer in the global HA application field, Singclean Medical redefines the industry standard of medical-grade hyaluronic acid products through breakthrough technologies. At the exhibition, its core product, cross-linked hyaluronic acid gel for orthopedic injection, attracted many orthopedic experts and distributors to stop and negotiate with its characteristics of long-term lubrication and precise repair of joint injuries; while Viscoelastic Solution for Ophthalmic Surgery have become the focus of attention of Turkish ophthalmology institutions with their high biocompatibility and safety. In addition, the new series of medical-grade skin care products launched by Singclean Medical for the first time combines HA technology with innovative functional ingredients to provide consumers with "medical research and co-creation" skin health solutions, further expanding the brand's influence in the consumer medical market.
This exhibition marks a key step in Singclean's strategic layout in the Middle East and Eurasian markets. Singclean's Middle East market manager revealed that in the future, Turkey will be used as a fulcrum to work with local partners to promote the landing of the HA technology research and development center, and to develop customized products based on regional needs, and deeply participate in the construction of the "Health Silk Road".
EXPOMED EURASIA 2025 is not only an industry feast, but also an important milestone in Singclean's globalization process. Through technology output and localization integration, Singclean is injecting new vitality into the Eurasian medical and health ecosystem with the power of "China's Smart Manufacturing".








